ChartMill assigns a Buy % Consensus number of 80% to FLGT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-05 | UBS | Upgrade | Neutral -> Buy |
| 2025-08-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-05 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-03-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-03-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-12-07 | UBS | Initiate | Neutral |
| 2023-10-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-03-02 | Credit Suisse | Maintains | Outperform |
| 2022-12-08 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-11-18 | Raymond James | Initiate | Outperform |
| 2022-11-14 | Credit Suisse | Maintains | Outperform |
| 2022-11-14 | Piper Sandler | Maintains | Overweight |
| 2022-08-25 | Credit Suisse | Initiate | Outperform |
| 2022-05-16 | Piper Sandler | Maintains | Overweight |
| 2022-01-25 | Oppenheimer | Maintains | Outperform |
| 2021-08-10 | Credit Suisse | Maintains | Underperform |
| 2021-03-05 | Piper Sandler | Maintains | Overweight |
9 analysts have analysed FLGT and the average price target is 34.34 USD. This implies a price increase of 23.26% is expected in the next year compared to the current price of 27.8601.
The consensus rating for FULGENT GENETICS INC (FLGT) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering FULGENT GENETICS INC (FLGT) is 9.